Non-myeloablative conditioning with allogeneic progenitor cell transplantation for relapsed Hodgkin's lymphoma: High response rate despite prior chemoresistance.

被引：0
|
作者：
Goldstein, SC
Luger, SM
Stadtmauer, E
Schuster, S
Tsai, D
Nasta, S
Loren, A
Perl, A
Orloff, G
Oliver, J
Sachs, R
Emerson, S
Porter, DL
机构：
[1] Univ Penn, Bone Marrow & Stem Cell Transplant Program, Ctr Canc, Philadelphia, PA 19104 USA
[2] Fairfax Prince William Hematol Oncol, Fairfax, VA USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.2258.2258
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2258
引用
收藏
页码：621A / 622A
页数：2
相关论文
共 50 条
  • [31] Allogeneic Stem Cell Transplantation With Reduced Intensity Conditioning Regimen In Patients With Relapsed Hodgkin's Lymphoma
    Rivas, Maria Marta
    Berro, Mariano
    Yantorno, Sebastian
    Prates, Maria Virginia
    Milone, Jorge H.
    Basquiera, Ana Lisa
    Berreta, Adriana
    Garcia, Juan
    Remaggi, Guillermina
    Rolon, Juliana Martinez
    Arbelbide, Jorge
    Makiya, Monica
    Dibar, Eduardo
    Requejo, Alejandro
    Feldman, Leonardo Julio, Sr.
    Milovic, Vera
    Foncuberta, Maria Cecilia
    Burgos, Ruben
    Kusminsky, Gustavo Daniel
    BLOOD, 2013, 122 (21)
  • [32] Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia
    Ram, Ron
    Storb, Rainer
    Sandmaier, Brenda M.
    Maloney, David G.
    Woolfrey, Ann
    Flowers, Mary E. D.
    Maris, Michael B.
    Laport, Ginna G.
    Chauncey, Thomas R.
    Lange, Thoralf
    Langston, Amelia A.
    Storer, Barry
    Georges, George E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (08): : 1113 - 1120
  • [33] High response rate to lenalidomide in relapsed/refractory aggressive non-Hodgkin's lymphoma with prior stem cell transplant
    Vose, Julie M.
    Tuscano, Joseph M.
    Justice, Glen
    Lossos, Izidore S.
    Ervin-Haynes, Annette
    Takeshita, Kenichi
    Pietronigro, Dennis
    Zeldis, Jerome B.
    Habermann, Thomas M.
    BLOOD, 2007, 110 (11) : 757A - 758A
  • [34] Non-myeloablative allogeneic hematopoietic transplantation: A promising salvage therapy for patients with non-Hodgkin's lymphoma (NHL) whose disease has failed a prior autologous stem cell transplantation (ASCT).
    Escalon, MP
    Richard, C
    Saliba, RM
    Acholonu, S
    Hosing, C
    Fayad, L
    Ueno, NT
    Pro, B
    Giralt, S
    McLaughlin, P
    Issa, IF
    BLOOD, 2003, 102 (11) : 75A - 76A
  • [35] Long-term outcomes of non-myeloablative allogeneic stem cell transplantation (alloSCT) in patients with relapsed mantle cell lymphoma (MCL).
    Khouri, Issa F.
    Wang, Xuemei
    Turturro, Francesco
    Jabbour, Elias
    Carballo-Zarate, Adrian A.
    Korbling, Martin
    Alousi, Amin Majid
    Oran, Betul
    Anderlini, Paolo
    Ciurea, Stefan O.
    Patel, Krina K.
    Marin, David
    Nastoupil, Loretta J.
    Fanale, Michelle A.
    Samuels, Barry I.
    Gulbis, Alison M.
    Medeiros, L. Jeffrey
    Khoury, Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [36] Comparison of non-myeloablative and reduced-intensity conditioning prior to allogeneic stem cell transplantation in older patients with myelodysplastic syndrome
    Jentzsch, Madlen
    Pfrepper, Christian
    Linke, Richard
    Doehring, Christine
    Grimm, Juliane
    Beinicke, Stefanie
    Haentschel, Janine
    Hille, Andrea
    Poenisch, Wolfram
    Vucinic, Vladan
    Franke, Georg-Nikolaus
    Behre, Gerhard
    Niederwieser, Dietger
    Schwind, Sebastian
    BONE MARROW TRANSPLANTATION, 2018, 53 : 268 - 269
  • [37] Allogeneic stem cell transplantation using non-myeloablative conditioning regimens: Results of the Mexican approach
    Guillermo J. Ruiz-Argüelles
    International Journal of Hematology, 2002, 76 : 376 - 379
  • [38] Non-myeloablative conditioning before allogeneic stem cell transplantation in adult acute lymphoblastic leukemia
    Gökbuget, N
    Hoelzer, D
    HAEMATOLOGICA, 2003, 88 (05) : 484 - 486
  • [39] The role of allogeneic hematopoietic cell transplantation with non-myeloablative conditioning in chronic myeloid leukemia.
    Gurman, G
    Arat, M
    Soydan, E
    Dalva, K
    Ilhan, O
    Uysal, A
    Beksac, M
    BLOOD, 2001, 98 (11) : 375B - 376B
  • [40] Non-myeloablative conditioning regimen for allogeneic stem cell transplantation in patients with advanced hematological malignancies
    Malesevic, M
    Stamatovic, D
    Tukic, L
    Marjanovic, S
    Balint, B
    Tarabar, O
    Todoric, B
    Ristic, L
    Milicevic, S
    BONE MARROW TRANSPLANTATION, 2001, 27 : S294 - S295
12345